Related Experiment Video

Updated: Aug 20, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

IGF-1 and breast cancer

Per Eystein Lønning1, Svein Inge Helle

  • 1Section of Oncology, Institute of Medicine, Haukeland University Hospital, N-5021, Bergen, Norway.

Novartis Foundation Symposium
|November 26, 2004
PubMed

Insights

Targeting insulin-like growth factor-1 (IGF-1) offers a promising new strategy for breast cancer therapy. Research explores IGF-1

Area of Science:

  • Oncology
  • Molecular Biology
  • Endocrinology

Background:

  • Metastatic breast cancer remains incurable despite therapeutic advances.
  • Adjuvant therapy offers a 30% reduction in breast cancer mortality, highlighting the need for novel treatments.
  • Targeted therapies are gaining prominence in cancer treatment.

Purpose of the Study:

  • To discuss current strategies and findings for targeting the insulin-like growth factor (IGF)-1 pathway in breast cancer therapy.
  • To evaluate the role of IGF-1 as a potent mitogen and predictor of breast cancer risk.
  • To understand the interaction between endocrine treatments and the IGF system in breast cancer.

Main Methods:

  • Review of current research on IGF-1 receptor targeting in breast cancer.
  • Analysis of in vitro studies on IGF-1's mitogenic effects on breast cancer cells.
  • Examination of in vivo studies investigating endocrine treatments and IGF system interactions.

Main Results:

  • The insulin-like growth factor (IGF)-1 receptor is present in most breast cancers.
  • IGF-1 is a potent mitogen for breast cancer cells in vitro.
  • IGF-1 levels predict breast cancer risk in premenopausal patients.

Conclusions:

  • Targeting the IGF-1 pathway represents a potential therapeutic strategy for breast cancer.
  • Further research is needed to fully understand the impact of endocrine therapies on the IGF system and anti-tumorigenic effects.

More Related Videos

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

Spheroid Assay to Measure TGF-β-induced Invasion09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...